Home / Inspections / 1199216

FDA Inspection 1199216 — Oklahoma Blood Institute Northwest

Oklahoma Blood Institute Northwest — FEI 1626218

The FDA completed an inspection of Oklahoma Blood Institute Northwest on February 24, 2023 in Enid, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 24, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Enid, OK (United States)

Facility

Other inspections at this facility

  • 1068531 (NAI Wed Sep 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 976726 (NAI Thu May 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 856152 (NAI Wed Nov 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 756042 (NAI Fri Dec 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 606585 (NAI Thu Aug 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources